Common use of Terms Defined Elsewhere Clause in Contracts

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Term Section Agreement Preamble Biogen Idec License Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: Term 1.1(e) Aggregate Xxxxxx Payable Amount Section 1.1(f)(iii) Agreement Preamble Biogen Idec License Agreement Bankruptcy Cases Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 5.9 Company Preamble Company Common Stock Section 2.8 Board of Directors Recitals Company Board Recommendation Recitals Company Disclosure Schedule Letter Article IV II Company Expenses Schedule Party Section 2.13 1.1(f)(iii) Company Shares Recitals D&O Insurance Section 5.4(c) Enforceability Limitations Section 2.3(b) Equity Award Cash Consideration Section 1.1(h) Equity Award Xxxxxx Payment Section 1.1(h) Exculpation and Indemnification Agreements Section 5.4(b) Indemnified Parties Section 8.2(a)(ii5.4(a) Contracts Annex A-5 Xxxxxx Section 4.8(a1.1(f)(iii) Covered Xxxxxx Claim Section 1.1(f)(iii) Offer Recitals Offer Conditions Section 1.1(a)(iv) Offer to Purchase Section 1.1(a)(iii) Outside Date Section 6.1(d) Party (PartiesPreamble Per Member Xxxxxx Payable Amount Section 1.1(f)(i) Per Share Xxxxxx Payable Amount Section 8.2(a)(ii1.1(f)(ii) Damages Process Agent Section 8.2(a)(i7.9(c) DGCL Prospector Rig Acquisition Section 2.1 Document Retention 5.9 Purchaser Preamble Purchaser Disclosure Letter Article III Tail Period Section 2.12(f)(25.4(c) Drug Regulatory Agency Tender Offer Consideration Section 4.25 Effective 1.1(a)(ii) Tendering Members Recitals Termination Payment Section 6.2(b) Annex A-6 Annex B List of Tendering Members The information contained on this page has been redacted for confidentiality purposes. Annex B-1 The information contained on this page has been redacted for confidentiality purposes. The information contained on this page has been redacted for confidentiality purposes, other than the totals listed below. Total 3,407,072 67.90% *Percentages are rounded off to the nearest second decimal point and are calculated based on 5,017,556 total outstanding Shares as of the date hereof. Annex B-3 Annex C Form of Offer to Purchase (see attached) The attachment to this Annex C has been intentionally omitted. Annex X-0 Xxxxx X Xxx Xxxxxxxx Xxxxxxxx Xx the date falling 5 days before the agreed date for the Acceptance Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)and again immediately prior to the Acceptance Time, the Company shall provide Purchaser with responses to each of the following inquiries from the rig manager of each of the Prospector Rigs via electronic mail (from a company or ship email address):

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Section hereof in which such term is definedAgreement, as indicated below: Term Location Acquired Companies Acquired Company Interests Acquired Entity Deferred Compensation Plans Antitrust Division Recitals Recitals Section Agreement 5.2(g)(ii) Section 5.5(b) -22- Applicable Severance Plan Approval Section 5.2(c)(i) Section 5.7(c) Asset Basis Section 5.16(g)(i) Bankruptcy and Equity Principles Section 3.2 Basis Information Section 5.16(g)(i) Business CBA Section 3.19(a) Business Environmental Reports Section 5.25 Business Reports Section 3.11 Buyer Preamble Biogen Idec License Buyer 401(k) Plan Section 5.2(f)(i) Buyer Controlled Action Section 5.19(a) Buyer Deferred Compensation Plans Section 5.2(g)(i) Buyer Employee DCP Participants Section 5.2(g)(i) Buyer Indemnified Parties Section 8.2 Buyer Parent Recitals Buyer Parent Guarantee Recitals Buyer’s Allocation Section 5.16(a)(i) Cap Section 8.5(a)(i) Casualty Event Section 2.5(b) Casualty Event Notice Section 2.5(b) Casualty Loss Adjustment Site Section 2.5(c) Chosen Courts Section 9.1 claim Section 1.1 Claim Notice Section 8.4(b) Closing Section 2.3(a) Closing Cash Amounts Section 2.4(b) Closing Date Section 2.3(a) Closing Indebtedness Section 2.4(b) Closing Month Section 1.1 Closing Net Working Capital Section 2.4(b) Closing Section 338(h)(10) Election Amount Section 2.4(b) Collective Bargaining Agreement Section 4.7 Biogen Idec 3.19(a) Competing Business Section 5.26(b)(ii) Condemnation Action Section 5.28(a) Confidential Business Information Section 5.4(b) Continuation Period Section 5.2(c)(i) Corporate Policies Section 5.13 Covered Parties Section 5.17 COVID-19 Conditions Section 1.1 Current Representation Section 9.17(a) Cutoff Date Section 8.1(a) Damaged Retail Site Section 2.5(b) debt Section 1.1 Debt Financing Section 5.27(a) Deemed Section 338(h)(10) Election Transactions Section 5.16(e) Designated Person -23- Section 9.17(a) Disagreement Notice Section 2.4(c) Disclosing Party Section 5.4(c) Disputed Item Section 2.4(c) Divestiture Actions Section 5.5(c) Divestiture Event Section 5.26(d) DOL Section 3.21(c) Effective Time Section 2.3(a) Estimated Closing Cash Amounts Section 2.4(a)(i) Estimated Closing Indebtedness Section 2.4(a)(i) Estimated Net Working Capital Section 2.4(a)(i) Excluded Businesses Section 1.1 Excluded Marks Section 5.14(a) Excluded Retail Operations Section 5.26(b)(iv) Expenses Schedule Section 9.4(b) Final Allocation Section 5.16(a)(i) Final Cash Amounts Section 2.4(h) Final Closing Adjustment Section 2.4(j) Final Indebtedness Section 2.4(h) Final Net Working Capital Section 2.4(h) Final Purchase Price Section 2.4(j) Final Section 338(h)(10) Election Amount Section 2.4(h) FLSA Section 3.19(b) FTC Section 5.5(b) Governmental Filings Section 3.4 Grandfathered Participants Section 5.2(f)(ii) Incremental Fuel Supply Agreement Section 4.7 Books and Records 5.30(b) Indemnified Party Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e8.4(a) Indemnifying Party Section 8.3(a8.4(a) Instrument Independent Accounting Firm Section 2.12(c2.4(e) 9 Term Initial Purchase Price Section Merger 2.4(a)(ii) Interim Financial Statements Section 5.22(a) IRS Section 3.21(b) Like-Kind Exchange Section 5.16(l) Losses Section 8.2 Marketing Materials Section 5.27(a) Material Contract Section 3.18(a) Monetization Transaction Section 5.27(d) New Price Section 5.26(d) New Seller Deferred Compensation Plans Section 5.2(g)(ii) Non-Business Employee DCP Participants Section 5.2(g)(ii) Notice Period Section 8.4(b) Offer Notice Section 5.26(d) Offer Price Section 5.26(d) Outside Date Section 7.1(b) Partial Condemnation Actions Section 5.28(a) PBGC -24- Section 3.21(d) Permits Section 3.20(b) Post-Closing Representation Section 9.17(a) Pre-Closing Separate Tax Return Section 5.16(i)(i) Preliminary Adjustment Statement Section 2.4(b) Privileged Communications Section 9.17(b) R&W Insurance Policy Section 5.24 Resolution Period Section 2.4(e) Restricted Activities Section 5.26(a) Restricted Area Section 5.26(a) Restricted Parties Section 5.26(a) Retained Deferred Compensation Plans Section 5.2(g)(iii) Review Period Section 2.4(c) ROFO Section 5.26(d) ROFO Event Section 5.26(d) ROFO Notice Section 5.26(d) RSSP Section 5.2(f)(i) Sale Section 2.1 Merger Certificate Sale Notice Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent 5.26(d) Section 338(h)(10) Election Section 5.16(g)(i) Section 338(h)(10) Election Accounting Firm Section 5.16(g)(i) Section 338(h)(10) Election Amount Section 5.16(g)(i) Section 338(h)(10) Forms Section 5.16(g)(iii) Seller Controlled Action Section 5.19(a) Seller Deferred Compensation Plans Section 5.2(g)(i) Seller Guarantors Section 5.20(a) Seller Indemnified Parties Section 8.2(a)(i8.3 Seller Parent Preamble Seller Surviving Representations Section 8.1(a) parties Seller Thrift Plan Section 5.2(f)(i) Sellers Preamble Payee Separation Activities Section 8.5 Payor 5.7(a) Separation Plan Section 8.5 Per Diem Taxes 5.7(a) Service Credits Section 8.7(a5.2(c)(ii) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Signing Date Preamble Speedway Retirement Plan Sharing Amount Section 2.10(f5.2(e) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Stock Basis Section 2.12(b5.16(g)(i) Surviving Corporation Stock Purchase Subsidiaries Section 2.1 Third Milestone 5.16(g)(i) Straddle Period Section 2.10(g5.16(h)(i) Support Services Section 5.12 Tax Claim Section 5.16(k)(i) Tax Clearance Certificates Section 5.16(m) Terminating Contracts Section 5.11(a) Third Milestone Payment Amount Party Claim Section 2.10(g)8.4(b) Threshold Section 8.5(a)(i) Total Condemnation Actions Section 5.28(b) Transaction Accounting Principles -25- Section 1.1 Transferred Employees Transition Services Agreement Transportation Services Agreements Unclaimed Property Reports Section 5.2(a)(iii) Section 5.30(a) Section 5.30(c) Section 3.31 Union Section 3.19(a) Unresolved Items Section 2.4(f) willful and material breach -26- Section 7.2

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Term Section Agreement Acquisition Proposal Section 7.7(a) ARRA Section 4.11(g) Audited Financial Statements Section 6.13 Auditor’s Consent Section 6.13 Bankruptcy and Equity Exception Section 4.2(a) Buyer Preamble Biogen Idec License Agreement Business Software Section 4.7 Biogen Idec Supply Agreement 4.13(i) Buyer Indemnitees Section 4.7 Books and Records 12.2(a) Cap Section 2.12(f)(212.3(c)(i) Calculation Notice Section 3.2(b) Change In Control Customer Contracts Section 4.14(d) Closing Section 9.1 Closing Date Section 9.1 Closing Date Interest Rate Section 3.2(d) Term Section CMS Preamble CMS Group Charter Documents Section 4.1(b) CMS Group Release Section 7.8 COBRA Section 4.11(g) Coventry Preamble Cure Period Section 11.1(b) Deductible Section 12.3(a) Disputed Items Section 3.2(b) D&O Obligations Section 6.12 D&O Released Parties Section 12.6 Excluded Assets Section 2.2(a) FHC Recitals FHC Stock Recitals FHS Recitals FHS Closing Date Balance Sheet Section 3.2(a) FHS Closing Date Payment Section 2.4(a) FHS Estimated Working Capital Section 3.1(a) FHS Financial Statements Section 4.5(a) FHS Initial Calculation Section 3.2(a) FHS Interim Financial Statements Section 4.5(a) FHS Material Permits Section 4.17 FHS Negative Estimated Working Capital Adjustment Section 3.1(a) FHS Positive Estimated Working Capital Adjustment Section 3.1(a) FHS Restricted Business Section 7.3(a) FHS Stock Recitals FHS Working Capital Adjustment Amount Section 3.2(d) FHS Year End Financial Statements Section 4.5(a) Final FHS Working Capital Section 3.2(d) FIRPTA Affidavit Section 9.2(l) First Health Group Preamble Foreign Plans Section 4.11(h) Fundamental Representations Section 12.1(a) Governmental Damages Section 10.2(e) Governmental Investigation Section 10.2(e) HIPAA Section 4.11(g) Hired Employees Section 7.2(b)(i) HSR Filing Section 6.5(b) Indemnifiable Losses Section 12.2(b) Indemnification Notice Section 12.5(a) Indemnified Party Section 12.2(c) Infringes Section 4.13(b) Term Section Injunctions Section 10.1(b) Labor Union Section 4.12(a) Legal Actions Section 10.1(c) Loss of Profits Section 12.3(f) Material Contract Section 4.14(b) Party or Parties Preamble Policies Section 4.15 Property Taxes Section 8.2(b)(i) Provider Synergies Recitals Provider Synergies Interests Recitals Purchase Price Section 2.4(a) Re-Calculated FHS Working Capital Section 3.2(e) Re-Calculated FHS Working Capital Adjustment Amount Section 3.2(e) Registered IP Section 4.13(a) Related Persons Section 4.19 Releasing Parties Section 12.6 Restraints Section 10.1(c) Seller Indemnifiable Losses Section 12.2(b) Seller Indemnitees Section 12.2(b) Settlement Firm Section 3.2(c) Shares Recitals Tax Claim Notice Section 8.3(a) Closing Tax Return Notice Section 2.3 Closing 8.1(b)(i) Tax Settlement Firm Section 8.1(b)(i) Termination Date Section 2.3 Company Preamble Company Common Stock 11.1(e)(i) Third Party Claim Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii12.4(a) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Transfer Taxes Section 8.7(a8.2(a) Proceeding Unsold Securities Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)7.9

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: Term Section 2.01(e) Agreement Preamble Biogen Idec License Agreement Alternative Financing Section 4.7 Biogen Idec Supply Agreement 8.09(b) Alternative Financing Documents Section 4.7 Books and Records 8.09(b) Arbitrator Section 2.12(f)(211.08(b) Claim Notice Base Premium Section 8.3(a8.04(d) Change in the Company Recommendation Section 7.02(b) Closing Section 2.3 3.02 Closing Date Section 2.3 3.02 Company Preamble Company Common Stock Board Recitals Company Board Actions Recitals Company Board Recommendation Recitals Company Equity Interests Section 2.8 5.02(a) Company Disclosure Schedule Article IV Group Section 10.02(d) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 10.02(b) Competing Proposal Section 8.2(a)(ii7.02(d) Contracts Competition Laws Section 4.8(a5.05 Covered Persons Section 8.04(a) Covered Party (PartiesDebt Commitment Letter Section 6.05(a) Debt Financing Source Section 8.2(a)(ii6.05(a) Damages Deposit Agreement Section 8.2(a)(i) DGCL 4.05 Depositary Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 4.05 Effective Time Section 2.2 ERISA 3.03 Enforceability Exceptions Section 4.13(a5.03(a) ERISA Affiliate Expiration Time Section 4.13(a2.01(c)(ii)(B) Finally Determined Financing Section 8.5(b6.05(a) First Milestone Financing Condition Annex A Financing Document Section 2.10(e8.09(b) First Milestone Payment Amount GAAP Section 2.10(e5.06(b) Indemnifying Party Governmental Entity Section 8.3(a5.05 HKIAC Section 11.08(b) Instrument HKIAC Rules Section 2.12(c11.08(b) 9 Term Indemnification Agreements Section 8.04(a) Intervening Event Section 7.02(g) Intervening Event Termination Section 7.02(g) Legal Proceeding Section 6.06 Xxx Preamble Merger Recitals Merger Consideration Section 2.1 Merger Certificate 4.02(a) Minimum Condition Annex A Non-Required Remedy Section 2.2 Merger Sub Preamble 8.02(e) Offer Recitals Offer Conditions 2.01(a) Offer Documents Section 2.01(f) Offer Price Recitals Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Termination Fee Section 10.02(c) Parties Preamble Party Preamble Paying Agent Section 8.2(a)(i4.02(a) parties Preamble Payee Payment Fund Section 8.5 Payor 4.02(a) Per ADS Merger Consideration Section 8.5 4.01(b) Per Diem Taxes Share Merger Consideration Section 8.7(a4.01(a) Proceeding Plan of Merger Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment 3.03 Required Amount Section 2.10(f6.05(c) Stockholder Consent Xxxxxxxx-Xxxxx Act Section 5.06(a) Schedule TO Section 2.01(f) Schedule 13E-3 Section 2.02(b) Schedule 14D-9 Section 2.02(b) SEC Documents Section 5.06(a) Securities Act Section 5.06(a) Share Certificates Section 4.02(b)(i) Special Committee Recitals Stockholder Representative Special Committee Recommendation Recitals Super ROI Preamble Super Majority ROI Group Section 2.12(b10.02(d) Superior Proposal Section 7.02(f) Surviving Corporation Company Section 2.1 Third Milestone 3.01 Takeover Statute Section 2.10(g) Third Milestone Payment Amount 8.05 Transaction Litigation Section 2.10(g8.07 Transactions Recitals Uncertificated Shares Section 4.02(b)(i)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Section hereof in which such term is definedAgreement, as indicated below: Term Section Adverse Recommendation Change Section6.02(c) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2Section6.02(c) Claim Notice Section 8.3(aArbitrator Section10.08(b) Assumed Option Section3.03(b) Base Premium Section7.05(d) Benefit Plan Section4.15(b) BlueCity Holdings Limited Section2.06 Closing Section 2.3 Section2.02 Closing Date Section 2.3 Section2.02 Company Preamble Company Common Stock Section 2.8 Board Recitals Company Disclosure Schedule Article IV Board Recommendation Recitals Company Expenses Schedule Section 2.13 Equity Interests Section4.02(b) Company Indemnified Parties Section 8.2(a)(iiGroup Section9.02(h) Contracts Section 4.8(aCompany Termination Fee Section9.02(e) Competing Proposal Section6.02(g) Covered Party (PartiesPersons Section7.05(a) Section 8.2(a)(iiDeposit Agreement Section3.05 Depositary Section3.05 Dissenting Shareholders Section3.06(a) Damages Section 8.2(a)(iDissenting Shares Section3.06(a) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(aSection2.03 Enforceability Exceptions Section4.03 Equity Commitment Letter Section5.05(a) ERISA Affiliate Section 4.13(aEquity Financing Section5.05(a) Finally Determined Section 8.5(bExchange Ratio Section3.03(b) First Milestone Section 2.10(eFinancial Statements Section4.06(b) First Milestone Payment Amount Section 2.10(eHKIAC Section10.08(b) Indemnifying Party Section 8.3(aHKIAC Rules Section10.08(b) Instrument Section 2.12(cIndemnification Agreements Section7.05(a) 9 Term Section Insurance Policies Section4.18 Intervening Event Section6.02(e) Legal Proceeding Section5.08 Limited Guarantee Recitals Material Contracts Section4.16(a)(xiv) Merger Section 2.1 Recitals Merger Certificate Section 2.2 Consideration Section3.02(a) Merger Consideration Fund Section3.02(a) Merger Sub Preamble Nasdaq Section4.02(c) Non-Required Remedy Section7.02(d) Operating Subsidiary Section4.16(a)(xi) Parent Preamble Parent Disclosure Group Section9.02(h) Parent Termination Fee Section9.02(f) Parties Preamble Party Preamble Paying Agent Section3.02(a) Per ADS Merger Consideration Section3.01(b) Per Share Merger Consideration Section3.01(a) Plan of Merger Section2.03 PRC Subsidiaries Section4.09(a) Proxy Statement Section4.05 Record ADS Holders Section6.04(a) Record Date Section6.04(a) Registrar of Companies Section2.03 Rollover Shareholders Recitals Xxxxxxxx-Xxxxx Act Section4.06(a) Schedule Article V Parent Indemnified Parties Section 8.2(a)(i13E-3 Section6.03(a) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(aSEC Documents Section4.06(a) Proceeding Section 4.17 Royalties Section 2.10(hSecurities Act Section4.06(a) Second Milestone Section 2.10(fShare Certificates Section3.02(b)(i) Second Milestone Payment Amount Section 2.10(fSocial Insurance Section4.15(k) Stockholder Consent Special Committee Recitals Stockholder Representative Preamble Super Majority Section 2.12(bSuperior Proposal Section6.02(h) Support Agreement Recitals Surviving Corporation Section 2.1 Third Milestone Section 2.10(gCompany Section2.01 Takeover Statute Section4.23 Tax Returns Section4.13(a) Third Milestone Payment Amount Section 2.10(gTransaction Litigation Section7.08 Transactions Recitals U.S. GAAP Section4.06(b) Uncertificated Shares Section3.02(b)(i) VIE Contracts Section4.09(c)

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Term Section Accelerated Options Section 2.12(a) Acquisition Sub Preamble Affected Employees Section 6.9 Agreement Preamble Biogen Idec License Agreement Amended Severance Policy Section 4.7 Biogen Idec Supply Agreement 6.9 BRINC Preamble BRLLC Preamble Term Section 4.7 Books and Records BRLLC Expenses Section 2.12(f)(22.10(a) Certificate of Merger Section 2.3 Change of Control Payment Statement Section 2.10(c) Change of Control Payments Section 2.10(c) Claim Notice Section 8.3(a10.4(a) Closing Section 2.3 2.4(a) Closing Date Section 2.3 Company Preamble Company Common Stock 2.4(a) Closing Working Capital Section 2.8 Company 2.14(a)(i) Confidential Information Section 6.5(a)(i) Copyright Office Section 6.16(b) Customer Information Section 3.16 D&O Tail Section 6.19(b) Damages Section 10.2(a) Decline Date Section 2.14(e) Delivering Party Section 6.5(a)(ii) DGCL Recitals Disclosure Schedule Article IV Company Expenses Schedule III Dispute Notice Section 2.13 Company 10.4(b) Disputed Line Items Section 2.14(e) Dissenting Shares Section 2.16(a) Dissenting Shares Reduction Amount Section 2.16(b) DOJ Section 6.6 Effective Time Section 2.3 Environmental Costs Section 3.14(c)(ii) Equityholder Indemnified Parties Section 8.2(a)(ii10.2(b) Contracts Estimated Working Capital Section 4.8(a2.14(b) Covered Party (PartiesEstimated Working Capital Deficiency Section 2.14(c) EU Personal Data Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment 5.8 Excess Negative Adjustment Amount Section 2.10(e2.14(g) Indemnifying Party Expense Statement Section 8.3(a2.10(a) Instrument Final Tax Returns Section 2.12(c9.2(a)(i) 9 Term Form Working Capital Statement Section Merger 2.14(a)(i) FTC Section 2.1 Merger Certificate 6.6 Fundamental Representation Distributions Section 2.2 Merger Sub 10.2(d) Funded Indebtedness Statement Section 2.10(d) Gannett Preamble Parent Preamble Parent Disclosure Schedule Article V Parent General Survival Date Section 10.1 Indemnified Executive Section 6.19(a) Indemnity Escrow Amount Shortfall Section 2.14(g) Information Statement Section 6.3(a) Initial Calculation Section 2.14(d) Insolvent Section 5.6 Kenexa Indemnified Parties Section 8.2(a)(i10.2(a) parties Kenexa Technology Preamble Payee Labor Union Section 8.5 Payor 3.11(a)(i) Term Section 8.5 Per Diem Taxes Letter of Transmittal Section 8.7(a2.11(b) Proceeding Material Client Contract Section 4.17 Royalties 3.10(a)(i) Material Contracts Section 2.10(h3.10(a) Second Milestone Merger Section 2.10(f) Second Milestone Payment 2.2 Negative Adjustment Amount Section 2.10(f2.14(f) Stockholder Consent Recitals Stockholder Notice of Disagreement Section 2.14(e) Off-the-Shelf Software Section 3.15(c) Organizational Documents Section 2.4(c)(ii) Outside Date Section 8.1(b) Parent Preamble Positive Adjustment Amount Section 2.14(f) Post Preamble Privacy Policy Section 3.16 Qualified Plan Section 3.11(b)(ii)(I) Receiving Party Section 6.5(a)(iii) Registered Intellectual Property Section 3.15(e) Regulatory Agreements Section 3.25(b) Relevant Group Section 3.13(a)(i) Representative Preamble Super Majority Required Exchange Documents Section 2.12(b2.11(b) Requisite BRINC Vote Section 3.3(b) Safe Harbor Section 5.8 Selling Members Recitals Settlement Accountants Section 2.14(e) Severance Payment Statement Section 2.10(b) Severance Payments Section 2.10(b) Straddle Periods Section 9.2(a)(ii) Surviving Corporation Section 2.2 Takeover Statutes Section 3.25(a)(iii) Tax or Taxes Section 3.13(a)(ii) Tax Return Section 3.13(a)(iii) Terminated Plan Section 3.11(b)(i) Transactions Section 2.4(a) Transfer Section 2.1 Third Milestone Transfer Taxes Section 2.10(g3.13(a)(iv) Third Milestone Payment Amount Tribune Preamble USPTO Section 2.10(g6.16(b) WARN Act Section 3.11(a)(i)

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: Defined Term Reference Acquired Entities Preamble Adjustment Escrow Account Section 2.6(c)(iv)(C) Agreement Preamble Biogen Idec License Alternative Transaction Section 7.19 Antitrust Laws Section 7.2(c) Assigned IP Section 7.20(c) Binder Agreement Section 4.7 Biogen Idec Supply 7.3 Blocker Interests Recitals Buyer Preamble Buyer Parent Preamble Buyer Parent Guaranty Section 9.15(a) Buyer Tax Contest Section 7.5(b) Class D Preferred Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) 6.7 Closing Section 2.3 2.5 Closing Date Section 2.3 2.5 Closing Item Section 2.4(a) Closing Statement Section 2.4(a) Company Preamble Company Common Stock Employee Benefit Plan Section 2.8 3.15(a) Company Disclosure Schedule Article IV Interests Recitals Company Proprietary Rights Section 3.10(a) Continuing Employees Section 7.13 control Section 1.1 D&O Provisions Section 7.9(a) Debt Commitment Letters Section 6.7 13 Defined Term Reference Debt Documents Section 7.16(b) Deposit Recitals Direct Company Interests Recitals Dispute Notice Section 2.4(b) Environmental Permits Section 3.18 Escrow Agreement Section 2.6(b)(v)(D) Estimated Cash Section 2.3 Estimated Closing Statement Section 2.3 Estimated Indebtedness Section 2.3 Estimated Leakage Section 2.3 Estimated Post-Effective Time Capital Contribution Reimbursement Amount Section 2.3 Estimated Reorganization Liabilites Section 2.3 Estimated Transaction Expenses Section 2.3 Estimated Working Capital Section 2.3 Excess Amount Section 2.4(d) Final Cash Section 2.4(a) Final Indebtedness Section 2.4(a) Final Leakage Section 2.4(a) Final Post-Effective Time Capital Contribution Reimbursement Amount Section 2.4(a) Final Reorganization Liabilities Section 2.4(a) Final Transaction Expenses Section 2.4(a) Final Working Capital Section 2.4(a) Financial Statements Section 3.5 GGC Blockers Preamble HEP ShaleApps Recitals Hillstone Asset Assignment Section 2.6(b)(v)(C) Hillstone Assigned Assets Section 7.20 Hillstone Parent Preamble Indemnified Persons Section 7.9(a) Indirect Company Interests Recitals IP Assignment Section 2.6(b)(v)(C) IRS Section 3.15(a) K&E Section 9.12 Latest Balance Sheet Section 3.5 Material Contract Section 3.9(b) Material Permits Section 3.17(b) New Plans Section 7.13 NHLG Section 9.12 Non-Party Affiliate Section 7.22 Obligations Section 9.15(a) Ordinary Course of Business Section 9.6 Outside Date Section 8.1(c) Payoff Letter Section 2.6(b)(v)(G) Party and Parties Preamble Parachute Payment Waiver Section 7.14 Performance Demand Section 9.15(a) Permitted Capital Expenditures Section 3.6(s) Pre-Closing Reorganization Recitals Pre-Closing Reorganization Agreement Recitals Pre-Signing Reorganization Recitals Defined Term Reference Pre-Signing Reorganization Agreements Recitals Post-Closing Representation Section 9.12 Pre-Closing Period Section 7.1(c)(i) Preferred Investment Section 6.7 Purchased Equity Recitals Purchased Equity Assignment Section 2.6(b)(v)(B) Purchase Price Allocation Schedule Section 2.13 Company Indemnified 7.5(f) Remedial Action Section 7.2(c) Reorganization Agreements Recitals Resolution Period Section 2.4(b) Restriction Section 7.2(c) Retained Claims Amounts Section 7.12 Review Period Section 2.4(b) Rights-of-Way Section 3.7(e) R&W Insurance Policy Section 7.3 Seller Representative Preamble Selling Blocker Equityholders Preamble Seller Tax Contest Section 7.5(a) Sellers Preamble Shortfall Amount Section 2.4(e) Substitute Financing Section 7.16(d) Tail Policy Section 7.9(b) Target Restriction Section 7.2(c) Tax Contest Section 7.5(b) Transfer Taxes Section 7.5(d) Transition Services Agreement Section 2.6(b)(v)(H) Valuation Firm Section 2.4(b) Waiving Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)9.12

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Section hereof in which such term is definedAgreement, as indicated below: Term Section Agreement Preamble Biogen Idec License Agreement Arbitrator Section 4.7 Biogen Idec Supply Agreement 10.08(b) Base Premium Section 4.7 Books and Records 7.04(d) Change in Recommendation Section 2.12(f)(2) Claim Notice Section 8.3(a6.02(f) Closing Section 2.3 2.02 Closing Date Section 2.3 2.02 Company Preamble Company Common Stock Board Recitals Company Equity Interests Section 2.8 4.02(a) Company Disclosure Schedule Article IV Group Section 9.02(d) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.02(b) Competing Proposal Section 8.2(a)(ii6.02(e) Contracts Competition Laws Section 4.8(a4.05 Covered Persons Section 7.04(a) Covered Party (Parties) Deposit Agreement Section 8.2(a)(ii) Damages 3.05 Depositary Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 3.05 Effective Time Section 2.2 ERISA 2.03 Enforceability Exceptions Section 4.13(a4.03 GAAP Section 4.06(b) ERISA Affiliate Governmental Entity Section 4.13(a4.05 HKIAC Section 10.08(b) Finally Determined HKIAC Rules Section 8.5(b10.08(b) First Milestone Indemnification Agreements Section 2.10(e7.04(a) First Milestone Payment Amount Intervening Event Section 2.10(e6.02(h) Indemnifying Party Intervening Event Termination Section 8.3(a6.02(h) Instrument Legal Proceeding Section 2.12(c5.06 Limited Guarantee Recitals Merger Recitals Merger Consideration Section 3.02(a) 9 Term Merger Consideration Fund Section Merger Section 2.1 Merger Certificate Section 2.2 3.02(a) Merger Sub Preamble NASDAQ Section 4.02(a) Non-Required Remedy Section 7.02(e) Option Consideration Section 3.03(a) Parent Preamble Parent Disclosure Group Section 9.02(d) Parent Termination Fee Section 9.02(c) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Per ADS Merger Consideration Section 3.01(b) Per Share Merger Consideration Section 3.01(a) Plan of Merger Section 2.03 Record ADS Holders Section 6.03(c) Record Date Section 6.03(c) Rollover Agreement Recitals Rollover Shareholders Recitals RSU Consideration Section 3.03(c) Xxxxxxxx-Xxxxx Act Section 4.06(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.03(a) parties Preamble Payee SEC Documents Section 8.5 Payor 4.06(a) Securities Act Section 8.5 Per Diem Taxes 4.06(a) Special Committee Recitals Superior Proposal Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b6.02(g) Surviving Corporation Company Section 2.1 Third Milestone 2.01 Takeover Statute Section 2.10(g) Third Milestone Payment Amount 7.05 Transaction Litigation Section 2.10(g7.07 Transactions Recitals Uncertificated Shares Section 3.02(b)(i)

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms used have the meanings set forth in this Agreement and a reference to the Section hereof in which such term is definedSections indicated: Term Section 2017 Financial Statements Section 5.13(a) Acquisition Transaction Section 5.9 Agreement Preamble Biogen Idec License Agreement Agreements and Instruments Section 4.7 Biogen Idec Supply Agreement 4.12 Allocation Statement Section 4.7 Books and Records 2.7(a) Annual Financial Statements Section 2.12(f)(23.6 Antitrust Laws Section 5.4(b) Claim Notice Balance Sheet Section 8.3(a3.6 Balance Sheet Date Section 3.6 Basket Section 8.5(a) Cash Consideration Amount Section 2.2(a) Closing Section 7.4 Closing Cash Consideration Section 2.3 Closing Date Section 7.4 Closing Net Working Capital Section 2.4(a) Closing Statement Section 2.4(a) Company Released Parties Section 5.10(a) Cumulative Revenue Make Up Amount Section 2.5(a) Dispute Notice Section 2.4(b) 15 Term Section Disputed Amount Section 2.6(b) Earnout Recipients Section 2.5(d) Earnout Statement Section 2.5 Employee Benefit Plans Section 3.14(a) Equity Interests Recitals Estimated Closing Statement Section 2.3 Company Estimated Net Working Capital Section 2.3 FCPA Section 3.17(c) Financial Statements Section 3.6 Fraud Claims Section 8.1(b) X. Xxxxxx Guaranties Section 5.14 HSR Act Section 3.5(b) Indemnification Claim Section 8.4(a) Indemnity Cap Section 8.5(d) Insurance Policies Section 3.21 Interim Financial Statements Section 3.6 Leased Real Property Section 3.10(a) Losses Section 8.2(a) Material Contracts Section 3.13(a) Material Customers Section 3.24(a) Material Vendors Section 3.24(a) Non-Disclosure Agreement Section 5.6(a) NYSE Section 4.13 Objection Notice Section 2.5(c) Party and Parties Preamble Company Payoff Letters Section 7.1(i) Personal Property Leases Section 3.11 Purchaser Preamble Purchaser Common Stock Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.2(a) Purchaser Documents Section 2.13 Company 4.2 Purchaser Financial Statements Section 4.10 Purchaser Indemnified Parties Section 8.2(a)(ii8.2(a) Contracts Purchaser Plans Section 4.8(a6.1(b) Covered Party (PartiesPurchaser Preferred Stock Section 4.9(a) Purchaser SEC Documents Section 8.2(a)(ii4.11(a) Damages R&W Policy Premium Section 8.2(a)(i8.10 Real Property Leases Section 3.10(a) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 16 Term Section Merger 93 Required Quarter Financial Statements Section 2.1 Merger Certificate 5.13(a) Rights-of-Way Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent 3.10(a) SEC Section 4.10 Seller Documents Section 3.2 Seller Indemnified Parties Section 8.2(a)(i8.3 Sellers Representative Section 9.1(a) parties Sellers Preamble Payee Specified Creditors Section 8.5 Payor 2.3(b) Specified Indebtedness Section 8.5 Per Diem Taxes 2.3(b) Specified Indebtedness Statement Section 8.7(a2.3(b) Proceeding Tax Matter Section 4.17 Royalties 9.2(d) Termination Date Section 2.10(h7.5(a) Second Milestone Transaction Consideration Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)2.2

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: Defined Term Reference A&R GGPPA Section 6.1(f) Acquired Entity Benefit Plan Section 3.14(a) Affiliate Transaction Section 3.21 Agreement Preamble Biogen Idec License Agreement Antitrust Laws Section 4.7 Biogen Idec Supply Agreement 6.2(c) Balance Sheet Date Section 4.7 Books and Records 3.5(a) Buyers Preamble Carlsbad CIV Preamble Casualty Loss Section 2.12(f)(2) Claim Notice Section 8.3(a) 6.4 Closing Section 2.3 2.4 Closing Date Section 2.3 Company 2.4 control Section 1.1 D&O Provisions Section 6.10(a) ECP III Preamble Company Common Stock ECP III CIV Preamble ECP III-A Preamble ECP III-B Preamble ECP III-C Preamble ECP Parties Preamble Excess Payment Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 2.3(f)(i) Final Adjustment Certificate Section 2.13 Company 2.3(d) Final Settlement Date Section 2.3(c) Financial Statements Section 3.5(a) First Lien Debt Payoff Amount Section 2.5(b)(iii)(C) General Partner Preamble GP Buyer Preamble GP Interests Recitals Guarantee Section 8.14(a) Guarantor Preamble Holdings Recitals Indemnified Persons Section 6.10(a) Intended Tax Treatment Section 2.6(a) Xxxxxx & Xxxxxxx Section 8.11(a) LP Buyer Preamble LP Interest Sellers Preamble LP Interests Recitals Defined Term Reference Material Contract Section 3.10(b) Maximum D&O Premium Section 6.10(a) MOP Section 6.1(f) Multiemployer Plan Section 3.14(a) New Plans Section 6.13 Non-Continuing Employee Section 6.13 Nonparty Affiliates Section 6.17 Notice of Disagreement Section 2.3(c) Outside Date Section 7.1(c) Partnership Preamble Partnership Proprietary Rights Section 3.11(a) Party and Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Preamble Purchase Price Section 2.2 ERISA Purchase Price Allocation Section 4.13(a2.6(b) ERISA Affiliate R&W Insurance Policy Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment 6.3 Second Lien Debt Payoff Amount Section 2.10(e2.5(b)(iii)(D) Indemnifying Party Seller Representative Section 8.3(a8.13(a) Instrument Seller Representative Expense Account Section 2.12(c8.13(c) 9 Term Seller Tax Returns Section Merger 6.5(a) Sellers Preamble Sendero Carlsbad Finance Recitals Sendero Carlsbad Midstream Recitals Sendero Management Preamble Shortfall Payment Section 2.1 Merger Certificate 2.3(f)(i) Subject Interests Recitals Tail Policy Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties 6.10(a) Tax Contest Section 8.2(a)(i6.5(c) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Transfer Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g6.5(f)

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms (as capitalized below) will have the following meanings when used in this Agreement and a reference to the Agreement: Action Section hereof in which such term is defined: Term Section 5.10(b) Agreement Preamble Biogen Idec License Agreement Appraisal Rights Section 4.7 Biogen Idec Supply Agreement 2.1(b) Board of Directors Recitals Book-Entry Shares Section 4.7 Books and Records 2.2(a) Cancelled Shares Section 2.12(f)(22.1(a)(ii) Claim Notice Certificate of Merger Section 8.3(a1.3 Certificates Section 2.2(a) Change of Recommendation Section 5.4(e) Closing Section 2.3 1.2 Closing Date Section 2.3 1.2 Code Section 2.2(b)(iii) Common Stock Section 2.1(a)(i) Company Preamble Company Common Stock Disclosure Letter Article 3 Company Employees Section 2.8 5.6(a) Company Disclosure Schedule Article IV Post-Signing RSU Award Section 2.3(c) Company Expenses Schedule Section 2.13 Company Indemnified Related Parties Section 8.2(a)(ii7.3(a) Contracts Company SEC Reports Section 4.8(a3.5(a) Covered Party (PartiesCompany Stockholders’ Meeting Section 5.5(b) Company Termination Fee Section 8.2(a)(ii7.3(a) Damages Confidentiality Agreement Section 8.2(a)(i5.3(b) Development Real Property Section 3.9(e) DFARS Section 3.20(c) DGCL Recitals Dissenting Shares Section 2.1 Document Retention Period 2.1(b) EAR Section 2.12(f)(23.15(d) Drug Regulatory Agency Section 4.25 EXXXX Article 3 Effective Time Section 2.2 ERISA 1.3 End Date Section 4.13(a7.1(b) ERISA Affiliate ESPP Section 4.13(a3.2(b)(i) Finally Determined Exchange Fund Section 8.5(b2.2(a) First Milestone Filed SEC Reports Article 3 Financing Amounts Section 2.10(e4.12 HSR Act Section 3.4 Indemnified Party Section 5.10(b) First Milestone Payment Intervening Event Notice Section 5.4(f) Leases Section 3.9(a) Legal Restraint Section 6.1(b) Major Customer Section 3.13(a) Major Supplier Section 3.13(b) Material Contract Section 3.11(a) Maximum Amount Section 2.10(e5.10(c) Indemnifying Party Measurement Time Section 8.3(a3.2(a) Instrument Merger Recitals Merger Consideration Section 2.12(c2.1(a)(i) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble New Plans Section 5.6(b) Old Plans Section 5.6(b) Owned Real Property Section 3.9(a) Parent Preamble Parent Approvals Section 4.2(b) Parent Disclosure Schedule Letter Article V 4 Parent Indemnified Material Adverse Effect Section 4.1 Parent Related Parties Section 8.2(a)(i7.3(a) parties Preamble Payee Parent RSU Award Section 8.5 Payor 2.3(c)(i) Paying Agent Section 8.5 Per Diem Taxes 2.2(a) Proposed Dissenting Shares Section 8.7(a2.1(b) Proceeding Recommendation Section 4.17 Royalties 3.3 Remedial Action Section 2.10(h5.7(b) Second Milestone Representatives Section 2.10(f5.3(a) Second Milestone Payment Amount Required Company Stockholder Vote Section 2.10(f3.23 Sexual Misconduct Allegation Section 3.18(c) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Share Section 2.12(b2.1(a)(i) Specified Approvals Section 3.4 Standards Organization Section 3.10(b) Superior Proposal Notice Section 5.4(e) Surviving Corporation Section 2.1 Third Milestone 1.1 Takeover Statute Section 2.10(g3.22 Termination Date Section 5.1(a) Third Milestone Payment Amount WARN Act Section 2.10(g3.18(a)

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms (as capitalized below) will have the following meanings when used in this Agreement and a reference to the Section hereof in which such term is definedAgreement: Term Location Defined Action Section 6.11(b) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.5(b) Alternative Financing Section 4.7 Books and Records 6.16(a) Alternative Proposal Section 2.12(f)(26.5(k) Claim Notice Anti-Corruption Laws Section 4.13(b) Appraisal Rights Section 3.1(b) Approval Request Section 6.1(c) Book-Entry Shares Section 3.1(a)(i) Cancelled Shares Section 3.1(a)(ii) Capex Budget Section 4.11(a)(i) Certificate of Merger Section 2.3 Certificates Section 3.1(a)(i) Change of Recommendation Section 6.5(f) Closing Section 2.2 Closing Date Section 2.2 Code Section 3.2(b)(iii) Common Stock Section 3.1(a)(i) Company Preamble Company Board Recitals Company Disclosure Letter Article 4 Company Employee Section 6.7(a) Company Employees Section 6.7(a) Company Product Section 4.19 Company Related Parties Section 8.3(a) Closing Company SEC Reports Section 2.3 Closing Date 4.5(a) Company Stockholders’ Meeting Section 2.3 Company Preamble Company Common Stock 6.6(b) Confidentiality Agreement Section 2.8 Company Disclosure Schedule Article IV Company Expenses Schedule 6.3(b) control Definition of Affiliates, Section 2.13 Company Indemnified Parties 1.1 controlled by Definition of Affiliates, Section 8.2(a)(ii1.1 Converted Shares Section 3.1(a)(ii) Contracts Debt Commitment Letters Section 4.8(a5.11(a) Covered Party (Parties) Debt Financing Section 8.2(a)(ii) Damages Section 8.2(a)(i5.11(a) DGCL Recitals Dissenting Shares Section 2.1 Document Retention Period 3.1(b) Divestiture Action Section 2.12(f)(26.8(c) Drug Regulatory Agency DOJ Section 4.25 6.8(c) Effective Time Section 2.2 ERISA 2.3 End Date Section 4.13(a8.1(b) ERISA Affiliate Enforcement Expenses Section 4.13(a8.3(c) Finally Determined Exchange Fund Section 8.5(b3.2(a) Fee Letter Section 5.11(a) First Milestone Extended Date Section 2.10(e8.1(b) First Milestone Payment FTC Section 6.8(c) Funding Obligations Section 5.11(b) Funds Section 5.11(b) Go-Shop Period Section 6.4 Guaranteed Obligations Section 9.12(a) Guarantor Preamble Indemnified Party Section 6.11(b) Intervening Event Section 6.5(m) Intervening Event Notice Section 6.5(g) X.X. Xxxxxx Section 4.23 Leases Section 4.9(b) Legal Restraint Section 7.1(b) Material Contract Section 4.11(a) Maximum Amount Section 2.10(e6.11(c) Indemnifying Party Measurement Time Section 8.3(a4.2(a) Instrument Merger Recitals Merger Consideration Section 2.12(c3.1(a)(i) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Multiemployer Plan Section 4.16(f) New Plans Section 6.7(b) No-Shop Period Start Date Section 6.4 OFAC Definition of Economic Sanctions/Trade Wars, Section 1.1 Old Plans Section 6.7(b) Owned Real Property Section 4.9(a) Parent Preamble Parent Disclosure Schedule Letter Article V 5 Parent Indemnified Material Adverse Effect Section 5.1 Parent Related Parties Section 8.2(a)(i8.3(a) parties Parties Preamble Payee Party Preamble Paying Agent Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a3.2(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Payoff Amount Section 2.10(f6.21 Payoff Letter Section 6.21 Proposed Dissenting Shares Section 3.1(b) Recommendation Section 4.3 Remedial Action Section 6.8(c) Required Company Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Vote Section 2.12(b4.22 Share Section 3.1(a)(i) Significant Customers Section 4.20 Significant Suppliers Section 4.20 Specified Regulatory Approvals Section 7.1(c) Subject Refinancing Indebtedness Section 6.1(b)(ix) Superior Proposal Section 6.5(l) Superior Proposal Notice Section 6.5(f) Surviving Corporation Section 2.1 Third Milestone Takeover Statute Section 2.10(g4.21 Tax Proceeding Section 4.15(f) Third Milestone Payment Amount Tax Sharing Agreement Section 2.10(g4.15(l) Termination Date Section 6.1(a) U.S. Antitrust Agencies Section 6.8(c) under common control with Definition of Affiliates, Section 1.1 WARN Act Section 4.16(a)

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section Article hereof in which such term is defined: Term Section Actual Closing Balance Sheet Section 3.4(d) Actual Closing Date Cash Section 3.4(d) Actual Closing Date Indebtedness Section 3.4(d) Actual Working Capital Section 3.4(d) Acquisition Transaction Section 7.6(a) Adjusted Merger Consideration Section 3.4(f) Agreement Preamble Biogen Idec License Agreement Assumed Option Recitals Bankruptcy and Equity Exception Section 4.7 Biogen Idec Supply Agreement 4.2 Base Balance Sheet Section 4.7 Books 4.6 Base Merger Consideration Section 3.2(a)(i) Cash, Indebtedness and Records Expenses Schedule Section 2.12(f)(23.1(h) Claim Notice Certificate of Merger Section 8.3(a) 2.2 Closing Section 2.3 Closing Date Section 2.3 Common Stock Section 3.1(b) Company Preamble Company Common Stock Dissenting Shares Section 2.8 3.5 Company Terminating Breach Section 9.1(d) Continuing Employee Section 7.14(a) Deductible Section 10.4(a) DGCL Section 2.1 Disclosure Schedule Article IV Company Expenses Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 Employee Benefit Program Section 4.18(a) ERISA Section 4.13(a4.18(a) ERISA Affiliate Escrow Account Section 4.13(a3.3(a) Finally Determined Escrow Agent Section 8.5(b3.3(a) First Milestone Escrow Agreement Section 2.10(e3.3(a) First Milestone Payment Escrow Amount Section 2.10(e3.3(a) Estimated Closing Balance Sheet Section 3.4(a) Estimated Closing Date Cash Section 3.4(a) Estimated Closing Date Indebtedness Section 3.4(a) Estimated Working Capital Section 3.4(a) Excepted Representations Section 10.1 Final Closing Balance Sheet Section 3.4(b) Final Closing Date Cash Section 3.4(b) Final Closing Date Indebtedness Section 3.4(b) Final Working Capital Section 3.4(b) Financial Information Section 4.6 Firm Section 3.4(c) Fundamental Representations Section 10.1 HSR Act Section 4.2 Indemnified Party Section 10.3 Indemnifying Party Section 8.3(a10.3 Initial Merger Consideration Section 3.2(a) Instrument Interim Period Section 2.12(c7.1(a) 9 Term Investor Restricted Period Section 7.7(b) Investor Restricted Stockholder Section 7.7(b) Losses Section 10.2 Management Restricted Period Section 7.7(b) Management Restricted Stockholder Section 7.7(b) Material Contract Section 4.13 Material Stockholder Preamble Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble Parent Preamble Parent Disclosure Net Working Capital Target Section 3.2(a)(iii) November 30, 2007 Unaudited Financials Section 4.6 Objection Notice Section 3.4(c) Other Stockholders Recitals Parachute Payment Waiver Section 7.14(e) Payment Schedule Article V Parent Indemnified Parties Section 8.2(a)(i3.1(g) parties Preamble Payee Preferred Stock Section 8.5 Payor 3.1(b) Privacy Policy Section 8.5 Per Diem Taxes 4.13(d) Released Persons Section 8.7(a7.9 Reserve Account Section 3.2(e) Proceeding Special Representations Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent 10.1 Stockholders Recitals Stockholder Stockholders’ Representative Preamble Super Majority Stockholder Indemnified Party Section 2.12(b) 10.3 Stockholder Indemnifying Party Section 10.2 Surviving Corporation Section 2.1 Third Milestone Tax Reduction Section 2.10(g7.11(b) Third Milestone Payment Amount Termination Date Section 2.10(g)9.1(f) Ticketmaster Preamble Ticketmaster Indemnified Party Section 10.2 Ticketmaster Indemnifying Party Section 10.3 Ticketmaster Plans Section 7.14(b) Ticketmaster Shares Section 6.3(a) Ticketmaster Terminating Breach Section 9.1(e) Transactions Section 2.1

Terms Defined Elsewhere. The following is a list of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Term Section Acquisition Sub Preamble Aggregate Loss Threshold Section 8.3(a) Agreement Preamble Biogen Idec License Agreement Available NOL Amount Section 4.7 Biogen Idec Supply Agreement 2.15(c) CIC Amendment Section 4.7 Books and Records Section 2.12(f)(25.14(b) Claim Notice Section 8.3(a8.4(a) Closing Section 2.3 2.3(a) Closing Date Section 2.3 2.3(a) Closing Working Capital Section 2.13(a)(i) Company Preamble Company Common Stock Section 2.8 Company Disclosure Schedule Article IV III Company Expenses Schedule Intellectual Property Section 2.13 Company Indemnified Parties 3.17(a) Credits Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii2.15(a) Damages Section 8.2(a)(i8.2(a), (c) Decline Date Section 2.13(d) DGCL Section 2.1 Document Retention Period Dispute Notice Section 2.12(f)(28.4(b) Drug Regulatory Agency Disputed Line Items Section 4.25 2.13(d) Dissenting Shares Section 2.16(a) Dissenting Shares Reduction Amount Section 2.16(b) Effective Time Section 2.2 ERISA Equityholder Indemnified Parties Section 4.13(a8.2(b) ERISA Affiliate Estimated Working Capital Section 4.13(a2.13(b) Finally Determined Estimated Working Capital Adjustment Section 8.5(b2.13(b) First Milestone Final Working Capital Adjustment Section 2.10(e2.13(e) First Milestone Payment Amount Form Working Capital Statement Section 2.10(e2.13(a)(i) Indemnifying Term Section General Survival Date Section 8.1 Hireworks Section 5.15 Indemnified Officers Section 5.10 Indemnified Party Section 8.3(a8.4(a) Instrument Indemnitor Section 2.12(c8.4(b) 9 Term Initial Calculation Section 2.13(c) Kenexa Indemnified Parties Section 8.2(a) Kenexa Technology Preamble Labor Union Section 3.16(a)(i) Letter of Transmittal Section 2.10(b) Material Contracts Section 3.6(a) Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Net Adjustment Amount Section 2.13(f) NOL Adjustment Amount Section 2.15(c) NOL Study Section 2.15(b) NOLs Section 2.15(a) Notice of Disagreement Section 2.13(d) Notice of NOL Disagreement Section 2.15(c) Option Cancellation Agreement Section 2.11 Option Holder Section 3.4(c) Outside Date Section 7.1(b) Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Pre-Closing Taxes Section 5.11(a) Relevant Group Section 3.10(a)(i) Representative Preamble Representative Agreement Section 8.8(a) Representative Parties Section 8.2(a)(i8.8(f)(iii) parties Preamble Payee Settlement Accountants Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f2.13(d) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Approval Section 2.12(b3.3(b) Straddle Period Section 5.11(a) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Targeted Credit Amount Section 2.10(g2.15(a) Targeted NOL Amount Section 2.15(a) Tax or Taxes Section 3.10(a)(ii) Tax Return Section 3.10(a)(iii) Terminated Plan Section 3.16(b)(i) Transaction Expense Statement Section 2.9(a) Transfer Taxes Section 3.10(a)(iv)

Terms Defined Elsewhere. The For the purposes of this Agreement, the following is a list terms have the meanings specified in the indicated Sections of additional terms used in this Agreement and a reference to the Section hereof in which such term is definedAgreement: Defined Term Section Additional Individual Parties Preamble Additional Individual Party HoldCos Preamble Additional Number Section 3.2(b) Agreement Preamble Biogen Idec License Agreement Board Section 4.7 Biogen Idec Supply Agreement 1.2(a) Business Opportunity Section 4.7 Books and Records 11.7 CEO Section 2.12(f)(21.3 CFC Section 10.4 Chairman Section 1.2(c) Claim Company Preamble Compensation Committee Section 1.2(e) Confidential Information Section 8.1 Covered Transaction Section 3.5 Co-Sale Notice Section 8.3(a6.1 Co-Sale Pro Rata Portion Section 6.1(a) Closing Co-Sale Right Period Section 2.3 Closing 6.1 Director Section 1.2(a) Disclosing Party Section 8.4 Disposal Event Section 11.1(c)(i) Exercising ROFR Holder Section 5.2(b) First Participation Notice Section 3.2(a) First Refusal Expiration Notice Section 5.2(c) First Refusal Period Section 5.2(a) Founders Preamble Founder HoldCos Preamble HKIAC Section 12.12(b) HKIAC Rules Section 12.12(b) Information Rights Holder Section 1.1(a) Initiating Holders Section 2.2(b) Inspection Rights Section 1.1(c) Investors Preamble IPO Section 2.11(c) IPO Event Section 11.1(c)(i) Key Group Company Preamble Loan Outside Date Section 2.3 Company Preamble Company Common Stock Section 2.8 Company Disclosure 11.1(c)(i) MGJ OpCo Schedule Article IV Company Expenses A-1 MLS Schedule Section 2.13 Company Indemnified Parties Section 8.2(a)(ii) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention A-1 MLS OpCo Schedule A-1 Non-Competition Period Section 2.12(f)(211.4 Offered Shares Section 5.1 Onshore Equity Transfer Section 11.12 Onshore Personnel Replacement Section 11.12 Ordinary Director/Ordinary Directors Section 1.2(c) Drug Regulatory Agency Overallotment New Securities Section 4.25 Effective Time 3.2(b) Oversubscribing Right Participants Section 2.2 ERISA 3.2(b) Participation Rights Holder Section 4.13(a3.1 Party/Parties Preamble Permitted Transferee Section 4.4 PFIC Section 10.3 PFIC Shareholder Section 10.3 Preferred Director/Preferred Directors Section 1.2(b) ERISA Affiliate Prior Shareholders Agreement Recital (A) Re-allotment Period Section 4.13(a5.2(b) Finally Determined Re-allotment Share Number Section 8.5(b5.2(b) First Milestone Request Notice Section 2.10(e2.2(a) First Milestone Payment Amount Right of Participation Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)3.1

Terms Defined Elsewhere. The For purposes of this Agreement, each of the following is a list of additional terms (as capitalized below) when used in this Agreement and a reference will have the meaning ascribed to such term in the Section hereof in which set forth opposite such term is definedterm: Term 85 Action Section 5.10(b) Agreement Preamble Biogen Idec License Agreement Alternative Financing Section 4.7 Biogen Idec Supply Agreement 5.16(c) Alternative Proposal Section 4.7 Books and Records 5.4(g) Appraisal Rights Section 2.12(f)(22.1(b) Claim Notice Book-Entry Shares Section 8.3(a2.2(a) Burdensome Condition Section 5.7(c) Cancelled Shares Section 2.1(a)(ii) Certificate of Merger ‎Section 1.3 Certificates Section 2.2(a) Change of Recommendation Section 5.4(c) Closing Section 2.3 1.2 Closing Date Section 2.3 1.2 Code Section 2.2(b)(iii) Commitment Letter Section 4.6(a) Common Stock Section 2.1(a)(i) Company Preamble Company Common Stock Section 2.8 Board Recitals Company Disclosure Schedule Letter Article IV 3 Company Expenses Schedule PSU Consideration Section 2.13 2.3(c) Company Indemnified Recommendation Section 3.3 Company Registered IP Section 3.10(a) Company Related Parties ‎Section 7.3(d) Company RSU Consideration Section 8.2(a)(ii2.3(a) Contracts Company SEC Reports Section 4.8(a3.5(a) Covered Party (PartiesCompany Stockholder Approval Section 3.20 Company Stockholders’ Meeting ‎Section 5.5(b) Company Termination Fee Section 8.2(a)(ii7.3(a) Damages Confidentiality Agreement Section 8.2(a)(i5.3(b) Continuation Period Section 5.6(a) Data Breach Section 3.10(f) Data Protection Requirements Section 3.10(a) Definitive Agreements Section 5.16(a) DGCL Recitals Dissenting Shares Section 2.1 Document Retention Period Section 2.12(f)(22.1(b) Drug Regulatory Agency Section 4.25 XXXXX Article 3 Effective Time Section 2.2 ERISA 1.3 Employee Census ‎Section 3.15(g) End Date ‎Section 7.1(b) Filed SEC Reports Article 3 Financing Section 4.13(a4.6(a) ERISA Affiliate Financing Amounts Section 4.13(a4.6(d) Finally Determined Indemnified Party Section 8.5(b5.10(b) First Milestone Intervening Event Section 2.10(e5.4(i) First Milestone Payment Intervening Event Notice Section 5.4(e) Intervening Event Notice Period Section 5.4(e) Leases Section 3.9(a) Legal Restraint ‎Section 6.1(b) Lenders Section 4.6(a) Made Available to Parent Section 8.12 Material Contract Section 3.11(a) Maximum Amount Section 2.10(e5.10(c) Indemnifying Party Measurement Time Section 8.3(a3.2(a) Instrument Merger Recitals Merger Consideration Section 2.12(c2.1(a)(i) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble New Plans Section 5.6(b) Old Plans Section 5.6(b) Owned Real Property Section 3.9(a) Parent Preamble Parent Approvals Section 4.2(b) Parent Disclosure Schedule Letter Article V 4 Parent Indemnified Material Adverse Effect ‎Section 4.1 Parent Related Parties ‎Section 7.3(d) Parent RSU Section 8.2(a)(i2.3(b) parties Preamble Payee Parent Termination Fee Section 8.5 Payor 7.3(b)(i) Paying Agent Section 8.5 Per Diem Taxes 2.2(a) Payment Fund Section 8.7(a2.2(a) Proceeding Permitted Change of Recommendation Section 4.17 Royalties 5.4(e) Permitted Termination Section 2.10(h5.16(b) Second Milestone Prohibited Modifications Section 2.10(f5.16(b) Second Milestone Payment Amount Proposed Dissenting Shares Section 2.10(f2.1(b) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Representatives Section 2.12(b5.3(a) Share Section 2.1(a)(i) Subsidiary Shares Section 2.1(a)(i) Superior Proposal ‎Section 5.4(h) Superior Proposal Notice Section 5.4(d) Superior Proposal Notice Period ‎Section 5.4(c) Surviving Corporation Section 2.1 Third Milestone 1.1 Takeover Statute Section 2.10(g3.19 Tax Incentive ‎Section 3.15(g) Third Milestone Payment Amount Terminating Company PSU Section 2.10(g2.3(c) Terminating Company RSU Section 2.3(a) Termination Date Section 5.1(a)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: $ Section hereof in which such term is defined: Term 1.3(c) Adverse Recommendation Change Section 6.2(c) Agreement Preamble Biogen Idec License Alternative Acquisition Agreement Section 4.7 Biogen Idec Supply Agreement 6.2(c) Arbitrator Section 4.7 Books and Records 10.8(b) Base Premium Section 2.12(f)(27.4(d) Claim Notice CICL Section 8.3(a) 2.1 Closing Section 2.3 2.2 Closing Date Section 2.3 2.2 Company Preamble Company Common Stock Board Recitals Company Board Recommendation Recitals Company Equity Interests Section 2.8 4.2(a) Company Disclosure Schedule Article IV Group Section 9.2(h) Company Expenses Schedule Intellectual Property Rights Section 2.13 4.11(a) Company Indemnified Parties Termination Fee Section 8.2(a)(ii9.2(e) Contracts Competing Proposal Section 4.8(a6.2(g) Covered Party (PartiesPersons Section 7.4(a) Dissenting Shareholders Section 8.2(a)(ii3.3(a) Damages Dissenting Shares Section 8.2(a)(i3.3(a) DGCL Dollars Section 2.1 Document Retention Period Section 2.12(f)(21.3(c) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.3 Enforceability Exceptions Section 4.13(a4.3 Equity Commitment Letter Section 5.5(a) ERISA Affiliate Equity Financing Section 4.13(a5.5(a) Finally Determined Exchange Act Section 8.5(b4.5 Exchange Fund Section 3.2(a) First Milestone Financial Statements Section 2.10(e4.6(b) First Milestone Payment Amount Fuling Global, Inc. Section 2.10(e2.6 GAAP Section 4.6(b) Indemnifying Party Governmental Entity Section 8.3(a4.5 HKIAC Section 10.8(b) Instrument Indemnification Agreements Section 2.12(c7.4(a) 9 Term Legal Proceeding Section 4.12 Merger Recitals Merger Consideration Section 2.1 Merger Certificate Section 2.2 3.2(a) Merger Sub Preamble Nasdaq Section 4.5 Non-Required Remedy Section 7.2(e) Parent Preamble Parent Disclosure Group Section 9.2(h) Parent Termination Fee Section 9.2(f) Parties Preamble Party Preamble Paying Agent Section 3.2(a) Per Share Merger Consideration Section 3.1(a) Plan of Merger Section 2.3 Proxy Statement Section 4.5 Record Date Section 6.4(a) Regulatory Filings Section 4.5 Rollover Shareholders Recitals Rules Section 10.8(b) Xxxxxxxx-Xxxxx Act Section 4.6(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.3(a) parties Preamble Payee SEC Section 8.5 Payor 4.5 SEC Documents Section 8.5 Per Diem Taxes 4.6(a) Securities Act Section 8.7(a4.8 Share Certificates Section 3.2(b)(i) Proceeding Special Committee Recitals Superior Proposal Section 4.17 Royalties Section 2.10(h6.2(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Support Agreements Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Entity Section 2.1 Third Milestone Takeover Statute Section 2.10(g) Third Milestone Payment Amount 4.16 Transaction Litigation Section 2.10(g7.7 Transactions Recitals Uncertificated Shares Section 3.2(b)(i)

Terms Defined Elsewhere. The Each of the following is a list of additional terms used in this Agreement and a reference has the meaning ascribed to the Section hereof in which such term is definedin the Article or Section set forth opposite such term: Defined Term Reference Accounts Receivable Section 3.23(a) Additional Parent Filing Section 6.7(f) Agreement Preamble Biogen Idec License Alta Companies Interim Financial Statements Section 3.4(a) Altenative Acquisition Section 6.1(e) Alternative Financing Section 6.15(c) Antitrust Laws Section 6.2(c) Applicable Limitation Date Section 6.4(c) Bid Section 3.19(a) Binder Agreement Section 4.7 Biogen Idec Supply Agreement 6.3(a) Board Recitals Cash Consideration Section 4.7 Books and Records 1.1 Certificate of Merger Section 2.12(f)(22.1(d) Claim Notice Change in Recommendation Section 8.3(a6.7(f) Closing Section 2.3 2.1(c) Closing Date Section 2.3 2.1(c) Closing Form 8-K Section 6.7(g) Closing Press Release Section 6.7(g) Communication Policy Section 6.1(g) Company Preamble Company Common Stock Employee Benefit Plan Section 2.8 3.14(a) Company Disclosure Schedule Article IV Government Contract Section 3.19(a) Company Expenses Schedule Government Subcontract Section 2.13 3.19(a) Company Indemnified Parties Shareholder Approval Recitals Control Section 8.2(a)(ii1.1 Data Room Section 8.5 Debt Commitment Letters Section 5.6 Debt Financing Section 5.6 Definitive Debt Agreement Section 6.15(a) Contracts D&O Provisions Section 4.8(a6.11(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.1(d) Environmental Permits Section 4.13(a3.17 EquityHolder Preamble Equityholder Prepared Returns Section 6.6(a) ERISA Affiliate Excluded Shares Section 4.13(a2.2(b) Finally Determined Fee Letter Section 8.5(b5.6 Financial Statements Section 3.4(a) First Milestone Indemnified Persons Section 2.10(e6.11(a) First Milestone Payment Amount Indemnitee Section 2.10(e6.5(e) Indemnifying Party Indemnitor Section 8.3(a6.5(e) Instrument Intended Tax Treatment Recitals Interim Financial Statement Section 2.12(c3.4(a) 9 Term Internal Controls Section 3.4(b) IRS Section 3.14(a) Latest Balance Sheet Section 3.4(a) LTIP Section 6.1(d) Material Customer Section 3.9(c) Material Contract Section 3.9(b) Merger Section 2.1 Merger Certificate Section 2.2 Recitals Merger Sub Preamble NITCO Section 3.4(a) Non-Party Affiliate Section 6.14 Ordinary Course of Business Section 8.5 Outside Date Section 7.1(c) Parent Preamble Parent Disclosure Schedule Article V Prepared Returns Section 6.6(a) Parent Indemnified Parties Related party Section 8.2(a)(i7.3(b) parties Party Preamble Payee Permits Section 8.5 Payor 3.16(b) Per Share Merger Consideration Section 8.5 Per Diem 2.2(a) Pre-Closing Period Section 6.1(a) Registration Rights Agreement Section 2.4(b)(v)(I) Restrictive Covenants Section 6.16(d) R&W Deductible Section 6.3(a) R&W Insurance Company Section 6.3(a) R&W Insurance Policy Section 6.3(a) Signing Form 8-K Section 6.7(b) Signing Press Release Section 6.7(b) Stock Consdieration Section 1.1 Surviving Company Section 2.1(a) Tail Policy Section 6.11(b) Tax Contest Section 6.6(b) Third-Party Recovery Proceeds Section 6.5(d) Trade Controls Section 3.23(a) Trademarks Section 1.1 Transfer Taxes Section 8.7(a6.6(d) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)Article II TRANSACTION

Terms Defined Elsewhere. The For purposes of this Agreement, the following is a list of additional terms (as capitalized below) will have the following meanings when used in this Agreement and a reference to the Agreement: Action Section hereof in which such term is defined: Term Section 5.10(b) Agreement Preamble Biogen Idec License Agreement Appraisal Rights Section 4.7 Biogen Idec Supply Agreement 2.1(b) Board of Directors Recitals Book-Entry Shares Section 4.7 Books and Records 2.2(a) Cancelled Shares Section 2.12(f)(22.1(a)(ii) Claim Notice Certificate of Merger Section 8.3(a1.3 Certificates Section 2.2(a) Change of Recommendation Section 5.4(e) Closing Section 2.3 1.2 Closing Date Section 2.3 1.2 Code Section 2.2(b)(iii) Common Stock Section 2.1(a)(i) Company Preamble Company Common Stock Disclosure Letter Article 3 Company Employees Section 2.8 5.6(a) Company Disclosure Schedule Article IV Post-Signing RSU Award Section 2.3(c) Company Expenses Schedule Section 2.13 Company Indemnified Related Parties Section 8.2(a)(ii7.3(a) Contracts Company SEC Reports Section 4.8(a3.5(a) Covered Party (PartiesCompany Stockholders’ Meeting Section 5.5(b) Company Termination Fee Section 8.2(a)(ii7.3(a) Damages Confidentiality Agreement Section 8.2(a)(i5.3(b) Development Real Property Section 3.9(e) DFARS Section 3.20(c) DGCL Recitals Dissenting Shares Section 2.1 Document Retention Period 2.1(b) EAR Section 2.12(f)(23.15(d) Drug Regulatory Agency Section 4.25 XXXXX Article 3 Effective Time Section 2.2 ERISA 1.3 End Date Section 4.13(a7.1(b) ERISA Affiliate ESPP Section 4.13(a3.2(b)(i) Finally Determined Exchange Fund Section 8.5(b2.2(a) First Milestone Filed SEC Reports Article 3 Financing Amounts Section 2.10(e4.12 HSR Act Section 3.4 Indemnified Party Section 5.10(b) First Milestone Payment Intervening Event Notice Section 5.4(f) Leases Section 3.9(a) Legal Restraint Section 6.1(b) Major Customer Section 3.13(a) Major Supplier Section 3.13(b) Material Contract Section 3.11(a) Maximum Amount Section 2.10(e5.10(c) Indemnifying Party Measurement Time Section 8.3(a3.2(a) Instrument Merger Recitals Merger Consideration Section 2.12(c2.1(a)(i) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble New Plans Section 5.6(b) Old Plans Section 5.6(b) Owned Real Property Section 3.9(a) Parent Preamble Parent Approvals Section 4.2(b) Parent Disclosure Schedule Letter Article V 4 Parent Indemnified Material Adverse Effect Section 4.1 Parent Related Parties Section 8.2(a)(i7.3(a) parties Preamble Payee Parent RSU Award Section 8.5 Payor 2.3(c)(i) Paying Agent Section 8.5 Per Diem Taxes 2.2(a) Proposed Dissenting Shares Section 8.7(a2.1(b) Proceeding Recommendation Section 4.17 Royalties 3.3 Remedial Action Section 2.10(h5.7(b) Second Milestone Representatives Section 2.10(f5.3(a) Second Milestone Payment Amount Required Company Stockholder Vote Section 2.10(f3.23 Sexual Misconduct Allegation Section 3.18(c) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Share Section 2.12(b2.1(a)(i) Specified Approvals Section 3.4 Standards Organization Section 3.10(b) Superior Proposal Notice Section 5.4(e) Surviving Corporation Section 2.1 Third Milestone 1.1 Takeover Statute Section 2.10(g3.22 Termination Date Section 5.1(a) Third Milestone Payment Amount WARN Act Section 2.10(g3.18(a)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Action Section hereof in which such term is defined: Term Section 4.09 Agreement Preamble Biogen Idec License Agreement Arbitrator Section 4.7 Biogen Idec Supply Agreement 10.08(b) Base Premium Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a7.04(d) Closing Section 2.3 2.02 Closing Date Section 2.3 2.02 Company Preamble Company Common Stock Board Recitals Company Equity Interests Section 2.8 4.02(a) Company Disclosure Schedule Article IV Group Section 9.02(d) Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.02(b) Competing Proposal Section 8.2(a)(ii) Contracts Section 4.8(a6.02(d) Covered Party (PartiesPersons Section 7.04(a) Deposit Agreement Section 8.2(a)(ii3.05 Depositary Section 3.05 Dissent Notice Section 3.06(d) Damages Dissent Right Section 8.2(a)(i3.06(d) DGCL Dissenting Shareholders Section 2.1 Document Retention Period 3.06(a) Dissenting Shares Section 2.12(f)(23.06(a) Drug Regulatory Agency Section 4.25 Effective Time Section 2.2 ERISA 2.03 Enforceability Exceptions Section 4.13(a4.03 Equity Commitment Letter Section 5.05(a) ERISA Affiliate Equity Commitment Letters Section 4.13(a5.05(a) Finally Determined Equity Financing Section 8.5(b5.05(a) First Milestone GAAP Section 2.10(e4.06(b) First Milestone Payment Amount Governmental Entity Section 2.10(e4.05 HKIAC Section 10.08(b) Indemnifying Party HKIAC Rules Section 8.3(a10.08(b) Instrument 4 Indemnification Agreements Section 2.12(c7.04(a) 9 Term Intervening Event Section 6.02(h) Intervening Event Termination Section 6.02(h) Legal Proceeding Section 5.06 Limited Guarantee Recitals Merger Recitals Merger Consideration Section 2.1 3.02(a) Merger Certificate Consideration Fund Section 2.2 3.02(a) Merger Sub Preamble Non-Required Remedy Section 7.02(d) NYSE Section 4.02(a) OTC Market Section 4.02(a) Parent Preamble Parent Disclosure Group Section 9.02(d) Parent Termination Fee Section 9.02(c) Parties Preamble Party Preamble Paying Agent Section 3.02(a) Per ADS Merger Consideration Section 3.01(b) Per Share Merger Consideration Section 3.01(a) Plan of Merger Section 2.03 Record ADS Holders Section 6.03(c) Record Date Section 6.03(c) Rollover Agreements Recitals Rollover Shareholders Recitals Xxxxxxxx-Xxxxx Act Section 4.06(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.03(a) parties Preamble Payee SEC Documents Section 8.5 Payor 4.06(a) Securities Act Section 8.5 Per Diem Taxes 4.06(a) Share Certificates Section 8.7(a3.02(b)(i) Proceeding Special Committee Recitals Superior Proposal Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b6.02(f) Surviving Corporation Company Section 2.1 Third Milestone 2.01 Takeover Statute Section 2.10(g) Third Milestone Payment Amount 7.05 Transaction Litigation Section 2.10(g7.07 Transactions Recitals Uncertificated Shares Section 3.02(b)(i)

Terms Defined Elsewhere. The following is a list terms have the meanings set forth in the Sections set forth below: Defined Term Location of additional terms used in this Agreement and a reference to the Section hereof in which such term is defined: Term Section Definitions Agreement Preamble Biogen Idec License Agreement Arbitrator Section 4.7 Biogen Idec Supply Agreement 10.8(b) Available Cash Section 4.7 Books and Records 7.13 Base Premium Section 2.12(f)(27.4(d) Claim Notice Change in Recommendation Section 8.3(a6.2(d) Closing Section 2.3 Closing Date Section 2.3 Company Preamble Company Common Stock Board Recitals Company Group Section 2.8 9.2(d) Company Disclosure Schedule Article IV Company Expenses Schedule Termination Fee Section 2.13 Company Indemnified Parties 9.2(b) Confidential Information Section 8.2(a)(ii) Contracts Section 4.8(a10.11(c) Covered Party (PartiesPersons Section 7.4(a) Deposit Agreement Section 8.2(a)(ii3.5 Depositary Section 3.5 Deposited Available Cash Section 7.13 Dissent Notice Section 3.6(b)(ii) Damages Dissent Right Section 8.2(a)(i3.6(b) DGCL Dissenting Shareholders Section 2.1 Document Retention Period 3.6(a) Dissenting Shares Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 3.6 Effective Time Section 2.2 ERISA 2.3 Enforceability Exceptions Section 4.13(a4.3 Financing Section 5.6(a) ERISA Affiliate GAAP Section 4.13(a4.6(d) Finally Determined Governmental Entity Section 8.5(b4.5 HKIAC Section 10.8(b) First Milestone HKIAC Rules Section 2.10(e10.8(b) First Milestone Payment Amount Indemnification Agreements Section 2.10(e7.4(a) Indemnifying Party Intervening Event Section 8.3(a6.2(e) Instrument Intervening Event Termination Section 2.12(c6.2(e) 9 Term Limited Guarantee Recitals Loan Agreement Section 5.6(a) Material Company Permits Section 4.8 Merger Recitals Merger Consideration Section 2.1 3.2(a) Merger Certificate Consideration Fund Section 2.2 3.2(a) Merger Sub Preamble NASDAQ Section 4.2(b) Notice of Recommendation Change Section 6.2(d) Notice Period Section 6.2(d) Option Consideration Section 3.3(a)(i) Parent Preamble Parent Disclosure Group Section 9.2(d) Parent Termination Fee Section 9.2(c) 5 Parties Preamble Paying Agent Section 3.2(a) Per ADS Merger Consideration Section 3.1(b) Per Share Merger Consideration Section 3.1(a) Plan of Merger Section 2.3 Record ADS Holders Section 6.3(c) Record Date Section 6.3(c) Rollover Agreement Recitals Rollover Shareholders Recitals Ruhnn1106 Section 5.6(a) Xxxxxxxx-Xxxxx Act Section 4.6(a) Schedule Article V Parent Indemnified Parties 13E-3 Section 8.2(a)(i6.3(a) parties Preamble Payee SEC Documents Section 8.5 Payor 4.6(a) Securities Act Section 8.5 Per Diem Taxes 4.6(a) Share Certificates Section 8.7(a3.2(c)(i) Proceeding Special Committee Recitals Subscription Agreement Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b5.6(a) Surviving Corporation Company Section 2.1 Third Milestone Takeover Statute Section 2.10(g7.5 Transaction Litigation Section 7.8 Transactions Recitals Uncertificated Shares Section 3.2(c)(i) Third Milestone Payment Amount Vista Section 2.10(g5.6(a)

Terms Defined Elsewhere. The Solely for convenience, the following is a list of additional terms used that are defined in the section of this Agreement and a reference to the Section hereof in which set forth after each such term is definedbelow: Term Accounting Firm Section 3.2 Accounts Receivable Section 2.1(j) Agreement Preamble Biogen Idec License Agreement Allocation Schedule Section 4.7 Biogen Idec Supply Agreement 3.2 Alternate Debt Financing Section 4.7 7.18(c) Alternative Financing Commitment Section 7.18(c) Assumed Liabilities Section 2.3 Balance Sheet Date Section 5.6 Xxxx of Sale Section 4.2(a) Books and Records Section 2.12(f)(22.1(e) Business Related Software Section 5.14(b) Cash Purchase Price Section 3.1 Claim Notice Section 8.3(a10.4(a) Closing Section 2.3 4.1 Closing Date Section 2.3 4.1 Code Section 3.2 Company Cash Section 2.1(q) Comprint Preamble Company Common Stock Confidentiality Agreement Section 2.8 Company 7.4 Consents Section 5.5 Contract Section 2.1(g) Controversy Section 11.10 Disclosure Schedule Letter Article IV Company Expenses Schedule V Domain Name Assignment Section 2.13 Company Indemnified Parties Section 8.2(a)(ii4.2(c) Contracts Section 4.8(a) Covered Party (Parties) Section 8.2(a)(ii) Damages Section 8.2(a)(i) DGCL Section 2.1 Document Retention Period Section 2.12(f)(2) Drug Regulatory Agency Section 4.25 Effective Time Exchange Act Article V Excluded Assets Section 2.2 ERISA Financial Statements Section 4.13(a5.6 Financing Section 6.4 Financing Commitment Section 6.4 Flex Plan Section 7.16(f) ERISA Affiliate Form 8594 Section 4.13(a3.2 Grant Deed Section 4.2(b) Finally Determined Guarantor Preamble Xxxxx-Xxxxx Xxxx and Logo Section 8.5(b2.2(f) First Milestone HH Shoppers Preamble Indemnified Party Section 2.10(e) First Milestone Payment Amount Section 2.10(e10.4(a) Indemnifying Party Section 8.3(a10.4(a) Instrument of Assignment and Xxxx of Sale Section 2.12(c4.2(a) 9 Term Inventory Section Merger 2.1(i) Lease Assignment Section 2.1 Merger Certificate 4.2(e) Leased Real Property Section 2.2 Merger Sub Preamble 2.1(a)(ii) Licensed Software Section 5.14(b) Licenses and Permits Section 2.1(h) Machinery Section 2.1(c) Material Agreement Section 5.9(a) Natural Hazard Areas Section 11.20 Notice Section 11.10 Notice Period Section 10.4(c) Owned Real Property Section 2.1(a)(i) Parent Preamble Parent Disclosure Schedule Article V Benefit Plans Section 5.12 Parent Deductible Section 10.2(b)(i) Parent Indemnified Parties Section 8.2(a)(i10.3(a) parties Personal Property Leases Section 2.1(b) Party Preamble Payee Proprietary Software Section 8.5 Payor 5.14(b) Purchase Price Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation 3.1 Purchased Assets Section 2.1 Third Milestone Purchasers Preamble Purchasers Deductible Section 2.10(g10.3(b)(i) Third Milestone Payment Amount Purchasers Indemnified Parties Section 2.10(g10.2(a) Purchasers Plan Section 7.16(c) Purchasers Savings Plan Section 7.16(d) 8 RE Purchaser Preamble Response Section 11.10 Retained Liabilities Section 2.4 Reverse Termination Fee Section 9.2 SEC Article V Sellers Preamble Software Section 5.14(b) Tax Refunds Section 2.2(b) Trademark Assignment Section 4.2(c) Transfer Tax Returns Section 7.8(a) Transferred Employees Section 7.16(a) Transferred Intellectual Property Section 2.1(d) Transition Services Agreement Section 4.2(d)

Terms Defined Elsewhere. The following is a list of additional terms used are defined elsewhere in this Agreement and a reference to the Agreement, as indicated below: Acceptance Time Section hereof in which such term is defined: Term 1.1(e) Aggregate Xxxxxx Payable Amount Section 1.1(f)(iii) Agreement Preamble Biogen Idec License Agreement Bankruptcy Cases Section 4.7 Biogen Idec Supply Agreement Section 4.7 Books and Records Section 2.12(f)(2) Claim Notice Section 8.3(a) Closing Section 2.3 Closing Date Section 2.3 5.9 Company Preamble Company Common Stock Section 2.8 Board of Directors Recitals Company Board Recommendation Recitals Company Disclosure Schedule Letter Article IV II Company Expenses Schedule Party Section 2.13 1.1(f)(iii) Company Shares Recitals D&O Insurance Section 5.4(c) Enforceability Limitations Section 2.3(b) Equity Award Cash Consideration Section 1.1(h) Equity Award Xxxxxx Payment Section 1.1(h) Exculpation and Indemnification Agreements Section 5.4(b) Indemnified Parties Section 8.2(a)(ii5.4(a) Contracts Annex A-5 Xxxxxx Section 4.8(a1.1(f)(iii) Covered Xxxxxx Claim Section 1.1(f)(iii) Offer Recitals Offer Conditions Section 1.1(a)(iv) Offer to Purchase Section 1.1(a)(iii) Outside Date Section 6.1(d) Party (PartiesPreamble Per Member Xxxxxx Payable Amount Section 1.1(f)(i) Per Share Xxxxxx Payable Amount Section 8.2(a)(ii1.1(f)(ii) Damages Process Agent Section 8.2(a)(i7.9(c) DGCL Prospector Rig Acquisition Section 2.1 Document Retention 5.9 Purchaser Preamble Purchaser Disclosure Letter Article III Tail Period Section 2.12(f)(25.4(c) Drug Regulatory Agency Tender Offer Consideration Section 4.25 Effective 1.1(a)(ii) Tendering Members Recitals Termination Payment Section 6.2(b) Annex A-6 Annex B List of Tendering Members The information contained on this page has been redacted for confidentiality purposes. Annex B-1 The information contained on this page has been redacted for confidentiality purposes. Annex B-2 The information contained on this page has been redacted for confidentiality purposes, other than the totals listed below. Total 3,407,072 67.90% *Percentages are rounded off to the nearest second decimal point and are calculated based on 5,017,556 total outstanding Shares as of the date hereof. Annex B-3 Annex C Form of Offer to Purchase (see attached) The attachment to this Annex C has been intentionally omitted. Annex X-0 Xxxxx X Xxx Xxxxxxxx Xxxxxxxx Xx the date falling 5 days before the agreed date for the Acceptance Time Section 2.2 ERISA Section 4.13(a) ERISA Affiliate Section 4.13(a) Finally Determined Section 8.5(b) First Milestone Section 2.10(e) First Milestone Payment Amount Section 2.10(e) Indemnifying Party Section 8.3(a) Instrument Section 2.12(c) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble Parent Preamble Parent Disclosure Schedule Article V Parent Indemnified Parties Section 8.2(a)(i) parties Preamble Payee Section 8.5 Payor Section 8.5 Per Diem Taxes Section 8.7(a) Proceeding Section 4.17 Royalties Section 2.10(h) Second Milestone Section 2.10(f) Second Milestone Payment Amount Section 2.10(f) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Section 2.12(b) Surviving Corporation Section 2.1 Third Milestone Section 2.10(g) Third Milestone Payment Amount Section 2.10(g)and again immediately prior to the Acceptance Time, the Company shall provide Purchaser with responses to each of the following inquiries from the rig manager of each of the Prospector Rigs via electronic mail (from a company or ship email address):

Terms Defined Elsewhere. The For purposes of this Agreement, each of the following is a list of additional terms (as capitalized below) when used in this Agreement and a reference will have the meaning ascribed to such term in the Section hereof in which set forth opposite such term is definedterm: Term Action Section 5.10(b) Agreement Preamble Biogen Idec License Agreement Alternative Financing Section 4.7 Biogen Idec Supply Agreement 5.16(c) Alternative Proposal Section 4.7 Books and Records 5.4(g) Appraisal Rights Section 2.12(f)(22.1(b) Claim Notice Book-Entry Shares Section 8.3(a2.2(a) Burdensome Condition Section 5.7(c) Cancelled Shares Section 2.1(a)(ii) Certificate of Merger Section 1.3 Certificates Section 2.2(a) Change of Recommendation Section 5.4(c) Closing Section 2.3 1.2 Closing Date Section 2.3 1.2 Code Section 2.2(b)(iii) Commitment Letter Section 4.6(a) Common Stock Section 2.1(a)(i) Company Preamble Company Common Stock Section 2.8 Board Recitals Company Disclosure Schedule Letter Article IV 3 Company Expenses Schedule PSU Consideration Section 2.13 2.3(c) Company Indemnified Recommendation Section 3.3 Company Registered IP Section 3.10(a) Company Related Parties Section 8.2(a)(ii7.3(d) Contracts Company RSU Consideration Section 4.8(a2.3(a) Covered Party (PartiesCompany SEC Reports Section 3.5(a) Company Stockholder Approval Section 8.2(a)(ii3.20 Company Stockholders’ Meeting Section 5.5(b) Damages Company Termination Fee Section 8.2(a)(i7.3(a) Confidentiality Agreement Section 5.3(b) Continuation Period Section 5.6(a) Data Breach Section 3.10(a) Data Protection Requirements Section 3.10(f) Definitive Agreements Section 5.16(a) DGCL Recitals Dissenting Shares Section 2.1 Document Retention Period Section 2.12(f)(22.1(b) Drug Regulatory Agency Section 4.25 XXXXX Article 3 Effective Time Section 2.2 ERISA 1.3 Employee Census Section 4.13(a3.15(g) ERISA Affiliate End Date Section 4.13(a7.1(b) Finally Determined Filed SEC Reports Article 3 Financing Section 8.5(b4.6(a) First Milestone Financing Amounts Section 2.10(e4.6(d) First Milestone Payment Indemnified Party Section 5.10(b) Intervening Event Section 5.4(i) Intervening Event Notice Section 5.4(e) Intervening Event Notice Period Section 5.4(e) Leases Section 3.9(a) Legal Restraint Section 6.1(b) Lenders Section 4.6(a) Made Available to Parent Section 8.12 Material Contract Section 3.11(a) 83 Maximum Amount Section 2.10(e5.10(c) Indemnifying Party Measurement Time Section 8.3(a3.2(a) Instrument Merger Recitals Merger Consideration Section 2.12(c2.1(a)(i) 9 Term Section Merger Section 2.1 Merger Certificate Section 2.2 Merger Sub Preamble New Plans Section 5.6(b) Old Plans Section 5.6(b) Owned Real Property Section 3.9(a) Parent Preamble Parent Approvals Section 4.2(b) Parent Disclosure Schedule Letter Article V 4 Parent Indemnified Material Adverse Effect Section 4.1 Parent Related Parties Section 8.2(a)(i7.3(d) parties Preamble Payee Parent RSU Section 8.5 Payor 2.3(b) Parent Termination Fee Section 8.5 Per Diem Taxes 7.3(b)(i) Paying Agent Section 8.7(a2.2(a) Proceeding Payment Fund Section 4.17 Royalties 2.2(a) Permitted Change of Recommendation Section 2.10(h5.4(e) Second Milestone Permitted Termination Section 2.10(f5.16(b) Second Milestone Payment Amount Prohibited Modifications Section 2.10(f5.16(b) Stockholder Consent Recitals Stockholder Representative Preamble Super Majority Proposed Dissenting Shares Section 2.12(b2.1(b) Representatives Section 5.3(a) Share Section 2.1(a)(i) Subsidiary Shares Section 2.1(a)(i) Superior Proposal Section 5.4(h) Superior Proposal Notice Section 5.4(d) Superior Proposal Notice Period Section 5.4(c) Surviving Corporation Section 2.1 Third Milestone 1.1 Takeover Statute Section 2.10(g3.19 Tax Incentive Section 3.15(g) Third Milestone Payment Amount Terminating Company PSU Section 2.10(g)2.3(c) Terminating Company RSU Section 2.3(a) Termination Date Section 5.1(a) 84